drugset / Trial / NCT07674654
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.
Timeline
- Start
- 2026-07
- Primary completion
- 2028-06
- Completion
- 2028-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elismetrep | Small molecule | 10 mg | Oral |
| Subject | Elismetrep | Small molecule | 20 mg | Oral |